| License: Creative Commons Attribution 4.0 PDF - Submitted Version (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-365903
- DOI to cite this document:
- 10.5283/epub.36590
Abstract
Background: Hepatocellular carcinoma (HCC) is the 3rd leading cause of cancer-related death worldwide. The majority of HCCs are diagnosed in a stage that is not eligible for curative resection. For intermediate stage HCC, transarterial chemoembolization (TACE) is the recommended treatment. We evaluated the safety and efficacy of DSM (degradable starch microspheres) as embolic agent in ...
Owner only: item control page